You searched for "healthcare"
FOUNDATIONS OF INTRAOCULAR MICROSURGERY – Principles for Elite Performance Volume 1: Systemic Challenges
Cataract surgery is the most commonly performed intraocular surgery performed in the UK. It takes years of meticulous practice and experience to master the surgery and become a safe and slick surgeon. As the saying goes, “forewarned is forearmed.” Anticipating...Telemedicine strategies in ophthalmology: harnessing established and emerging technologies for lasting solutions
7 December 2020
| Rod McNeil
|
EYE - Vitreo-Retinal, EYE - Imaging, EYE - Oculoplastic, EYE - General
The author considers recent progress and shares insights from leading practitioners in telemedicine applications and digital technology strategies. Amidst COVID-19 and combined mitigation and suppression measures, hospitals and clinics have responded rapidly to strengthen telemedicine strategies and virtual healthcare services...
Understanding the inequalities of ophthalmic care for Indigenous people in a first world country
Aboriginal Australians have faced numerous challenges over the past centuries. Here in this article, Edward Saxton highlights why there are inequalities of ophthalmic care in Australia and why this has led to increased levels of blindness in Aboriginal people relative...
Risk of intraocular haemorrhage with new oral anticoagulants
1 December 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The authors conducted a study to assess the risk of intraocular haemorrhage with warfarin dabigatran, rivaroxaban, apixaban. All reported cases of intraocular haemorrhage (vitreous, choroidal, or retinal) with warfarin and new oral anticoagulants (NOACs) (including dabigatran, rivaroxaban, apixaban) from the...
The disease burden of AMD
1 December 2015
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
In this multi-centre, prospective, observational, time and motion study the authors assessed the time burden of managing wet AMD for doctors, staff, patients and caregivers in the USA. The study spanned the period from March 2011 to August 2012, and...
Is there an association between dry eye disease and depression and anxiety?
Dry eye disease is a widespread ocular surface condition (prevalence 5.5-33.7%) that has been previously linked to systemic diseases, such as Sjogren, rheumatoid arthritis and more recently possibly also depression, in small population-based studies. The authors’ aim was to investigate...
Insights in resistant diabetic macular oedema
5 August 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This article gives a bird’s eye review of the different modalities for the treatment of diabetic macular oedema (DME). The debut of anti-VEGFs has brought a paradigm shift in DME management. This treatment has now become a major breakthrough in...
Haag-Streit UK announces the launch of ‘Improving Outcomes’ Biometry Courses
18 July 2023
|
Research & Development
Haag-Streit UK is delighted to announce exclusive dates for two ‘Improving Outcomes’ biometry courses on Thursday 19th and Friday 20th October 2023 at our brand-new dedicated Academy facility.
Haag-Streit Academy 2024 course schedule released – book your place now!
27 November 2023
|
Awards, Conferences & Anniversaries, Research & Development
Haag-Streit Academy is pleased to launch it’s 2024 course schedule. The schedule features our popular CPD-accredited training and education events which include informative lectures and practical, hands-on workshops, delivered by industry experts.
Oertli Instrumente AG achieves milestone with FDA 510(k) clearance for Faros surgical system
24 July 2024
|
Research & Development
Oertli Instrumente AG, a leader in innovative surgical solutions for ophthalmology, is proud to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance for the worldwide established Faros anterior cataract surgery system. This milestone underscores Oertli's global reach and...
Vabysmo receives NICE approval
The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...Soluvos Medical provides A.R.C. Laser’s ophthalmic range in UK
29 January 2025
|
Company Profiles, Contracts & Distributors
Soluvos are thrilled to announce that they now provide A.R.C. Laser’s ophthalmic range, expanding their expertise to better serve the needs of eye care professionals. Designed to meet the highest standards in precision and reliability, enabling healthcare providers to deliver...
